Jon Nugent
Publisher
Jon Nugent is president and CEO of Jon Nugent Communications, an investor relations and strategic communications firm serving life sciences companies. For more than three decades, he has advised founders, executives and boards on investor positioning, financings and IPOs, clinical and regulatory milestones, M&A and long-term corporate strategy.
Jon has counseled more than 300 companies across North America, Europe, the Middle East and Asia. He has led teams at strategic communications firms in the United States and abroad and held senior in-house roles at multiple biotechnology companies.
Logan Mavar, Ph.D.
Senior Editor
Logan Mavar is vice president at Jon Nugent Communications, where she helps life sciences companies translate complex science into clear narratives for investors and strategic partners. Her work draws on experience in academic research, early-stage commercialization and biotechnology entrepreneurship.
Dr. Mavar holds a Ph.D. in Biotechnology from the University of Alabama at Birmingham, where she developed biomarker-detection technologies for cancer and infectious disease. Her scientific background includes microbiology, molecular biology, protein engineering and diagnostic-device development.